Mylan, Sunovion Reach Terms In Xopenex Patent Fight – site.law360.com
Law360, New York (May 29, 2012, 5:50 PM ET) -- Mylan Inc. said Tuesday it had settled a patent fight with Sunovion Pharmaceuticals Inc. over the asthma drug Xopenex, in a deal that will allow Mylan to continue selling its own version of the drug and ...
Subscribe to LegalLaw247.Com Newsletter